GSK3277510A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3277510A, covering 2016-06-20 to 2016-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age [Phase 1]